Plus Therapeutics Inc (PSTV)
Market Closed
27 Jul, 20:00
$
3. 73
-0.1
-2.611%
$
9.03M Market Cap
- P/E Ratio
- Div Yield
48,403 Volume
-2.41 Eps
$ 3.83
Previous Close 
Want to track PSTV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
PSTV Stock Skyrockets on FDA's Orphan Drug Tag for Cancer Therapy
The FDA bestows an Orphan Drug tag to Plus Therapeutics' investigational drug, rhenium (186Re) obisbemeda, for treating leptomeningeal metastases in lung cancer patients.
Zacks | 1 year ago
Plus Therapeutics, Inc. (PSTV) Q3 2024 Earnings Call Transcript
Plus Therapeutics, Inc. (NASDAQ:PSTV ) Q3 2024 Earnings Call Transcript November 14, 2024 5:00 PM ET Company Participants Marc Hedrick - President and CEO Andrew Sims - VP and CFO Conference Call Participants Justin Walsh - Jones Trading Edward Woo - Ascendiant Capital Sean Lee - H.C. Wainwright Operator Good afternoon, ladies and gentlemen.
Seekingalpha | 1 year ago
Plus Therapeutics, Inc. (PSTV) Q2 2024 Earnings Call Transcript
Plus Therapeutics, Inc. (PSTV) Q2 2024 Earnings Call Transcript
Seekingalpha | 1 year ago
